Abstract Hepatitis B virus (HBV) infection is a global public health problem. More than 2 billion people worldwide have evidence of past or current HBV infection and 350 million are chronic carriers of the virus, which is harboured in the liver and causes an estimated 600,000 deaths from cirrhosis of liver and Hepatocellular carcinoma.